Resmed (RSMDF) Acquisitions (2009 - 2026)

Resmed has reported Acquisitions for 17 years, with the latest figure at $24.9 million in Q1 2026.

• For the quarter ending Q1 2026, Acquisitions changed N/A year-over-year to $24.9 million; the trailing twelve-month figure through Mar 2026 stood at $163.1 million (up 668.67% YoY), and the FY2025 full-year result was $139.2 million, up 4.33% from the prior year.
• Acquisitions for Q1 2026 stood at $24.9 million, up from $522000.0 in the prior quarter.
• The five-year high for Acquisitions was $992.1 million in Q4 2022, with the low at $522000.0 in Q3 2025.
• Historically, Acquisitions has averaged $101.4 million across 5 years, with a median of $8.8 million in 2023.
• Annual changes were most pronounced in 2022 — Acquisitions jumped 2662.43% — and 2024, when it plunged 99.17%.
• Resmed's Acquisitions stood at $992.1 million in 2022, then slumped by 99.11% to $8.8 million in 2023, then slumped by 92.38% to $670000.0 in 2024, then decreased by 22.09% to $522000.0 in 2025, then surged by 4666.86% to $24.9 million in 2026.
• The last three Acquisitions figures came in at $24.9 million (Q1 2026), $522000.0 (Q3 2025), and $137.7 million (Q2 2025), per Business Quant data.